Cathay Innovation led a $38m funding round in AQEMIA.

Cathay Innovation, a global multi-stage venture capital fund, led a $38m funding round in AQEMIA, a pharmatech company company, with participation from Wendel, Bpifrance Large Venture, Eurazeo, and Elaia. “AQEMIA embodies the future of drug discovery, uniquely combining the power of AI and quantum mechanics to address theoretical questions around efficacy and bring potentially life-changing new drugs to market faster,” Jacky Abitbol, Cathay Innovation Partner.